| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |